Literature DB >> 10214763

Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease.

M K Sharief1, A Green, J P Dick, J Gawler, E J Thompson.   

Abstract

The authors report high intrathecal release of tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-1beta in five patients with sporadic or new-variant Creutzfeldt-Jakob disease (CJD) without activation of the humoral or lymphocytic immune responses. Increased release of TNF-alpha and IL-1beta was also detected in some patients with progressive dementias. CJD is associated with a local cerebral host response that involves the release of proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214763     DOI: 10.1212/wnl.52.6.1289

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

2.  Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever.

Authors:  S A Appel; J Chapman; E Kahana; H Rosenmann; I Prohovnik; E Pras; H Reznik-Wolf; O S Cohen
Journal:  Eur J Neurol       Date:  2010-01-20       Impact factor: 6.089

3.  An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.

Authors:  Leonardo Iaccarino; Rosa Maria Moresco; Luca Presotto; Orso Bugiani; Sandro Iannaccone; Giorgio Giaccone; Fabrizio Tagliavini; Daniela Perani
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

4.  Genomic and post-genomic analyses of human prion diseases.

Authors:  Maurizio Pocchiari; Anna Poleggi; Serena Principe; Silvia Graziano; Franco Cardone
Journal:  Genome Med       Date:  2009-06-22       Impact factor: 11.117

5.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

6.  Genes contributing to prion pathogenesis.

Authors:  Gültekin Tamgüney; Kurt Giles; David V Glidden; Pierre Lessard; Holger Wille; Patrick Tremblay; Darlene F Groth; Fruma Yehiely; Carsten Korth; Richard C Moore; Jörg Tatzelt; Eric Rubinstein; Claude Boucheix; Xiaoping Yang; Pamela Stanley; Michael P Lisanti; Raymond A Dwek; Pauline M Rudd; Jackob Moskovitz; Charles J Epstein; Tracey Dawson Cruz; William A Kuziel; Nobuyo Maeda; Jan Sap; Karen Hsiao Ashe; George A Carlson; Ina Tesseur; Tony Wyss-Coray; Lennart Mucke; Karl H Weisgraber; Robert W Mahley; Fred E Cohen; Stanley B Prusiner
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

Review 7.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

8.  Prion pathogenesis in the absence of NLRP3/ASC inflammasomes.

Authors:  Mario Nuvolone; Silvia Sorce; Petra Schwarz; Adriano Aguzzi
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

9.  Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease.

Authors:  Franc Llorens; Irene López-González; Katrin Thüne; Margarita Carmona; Saima Zafar; Olivier Andréoletti; Inga Zerr; Isidre Ferrer
Journal:  Front Aging Neurosci       Date:  2014-08-04       Impact factor: 5.750

10.  Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia.

Authors:  Koji Fujita; Naoko Matsui; Yukitoshi Takahashi; Yasushi Iwasaki; Mari Yoshida; Tatsuhiko Yuasa; Yuishin Izumi; Ryuji Kaji
Journal:  J Neuroinflammation       Date:  2013-11-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.